NVAX NOVAVAX INC Other Situations 8-K Filing 2023 - Settlement Agreement and Securities Subscription Agreement Novavax, Inc. entered into a Settlement Agreement with SK bioscience Co., Ltd. regarding the cancellation of certain statements of work and agreed to pay $149.75 million to SK. They also entered into a Securities Subscription Agreement with SK for the sale of 6,500,000 shares of common stock for approximately $84.5 million.Get access to all SEC 8-K filings of the NOVAVAX INC